EVEKEO ODT (amphetamine sulfate) · AZURITY
EVEKEO ODT is FDA-approved to treat 3 conditions (same as AMPHETAMINE SULFATE).
Details
- Status
- Discontinued
- First Approved
- 2019-01-30
- Patent Cliff
- 2037
- Routes
- ORAL
- Dosage Forms
- TABLET, ORALLY DISINTEGRATING
EVEKEO ODT Approval History
What EVEKEO ODT Treats
3 indicationsEVEKEO ODT is approved for 3 conditions since its original approval in 2019. These indications span multiple therapeutic areas including oncology, immunology, and more.
- Narcolepsy
- Attention Deficit Hyperactivity Disorder
- Exogenous Obesity
Same approved indications as AMPHETAMINE SULFATE (same active ingredient).
Clinical Trial Registry
1 trials| Trial | Sponsor ID | Phase | Status | Title |
|---|---|---|---|---|
| NCT03659929 results posted | AR19.004 | Ph 3 | completed | Adult Attention Deficit Hyperactivity Disorder (ADHD) Study With Amphetamine Sulfate |
Active Pipeline
Ongoing clinical trials by development phase
Key Completed Trials
Completed studies with published results, ranked by significance
Trial Timeline
Full development history with FDA approval milestones
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
EVEKEO ODT FDA Label Details
Indications & Usage
FDA Label (PDF)EVEKEO ODT is FDA-approved to treat 3 conditions — same approved indications as AMPHETAMINE SULFATE.
Pro Intelligence Preview
Deep insights for EVEKEO ODT
Revenue Insights
- • Quarterly revenue tracking
- • Historical trend analysis
Patent Timeline
- • Cliff: 2037
- • 70 active patents
Trial Analysis
- • Clinical trial tracking
- • Development stage analysis
Competitive Landscape
- • Competitor tracking
- • Same target/indication analysis
Full approval history • All patents • Revenue trends • Competitor analysis
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.